All practice questions

8270 questions

Question 2301Question →

A 42-year-old woman with a 3-year history of diffuse cutaneous systemic sclerosis comes to the emergency department due to a severe headache and blurred vision that began 24 hours ago. Her temperature is 37.0°C (98.6°F), blood pressure is 218/116 mm Hg, and pulse is 92/min. Physical examination shows tight, thickened skin over the face, trunk, and extremities. Laboratory studies show a serum creatinine of 2.9 mg/dL (baseline 0.9 mg/dL) and a hemoglobin of 10.2 g/dL. A peripheral blood smear reveals numerous schistocytes. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Administration of captopril

Answer

Administration of captopril
This patient's presentation of acute malignant hypertension, acute kidney injury, and microangiopathic hemolytic anemia in the setting of diffuse cutaneous systemic sclerosis is the classic description of Scleroderma Renal Crisis (SRC). The underlying pathophysiology involves thickening of the renal arcuate and interlobular arteries, leading to decreased renal perfusion, massive renin release, and subsequent severe hypertension. The cornerstone of life-saving therapy is the prompt administration of an angiotensin-converting enzyme (ACE) inhibitor, classically captopril. ACE inhibitors directly block the maladaptive renin-angiotensin-aldosterone system cascade, relieving renal vasoconstriction.

Step-by-Step Solution

1
Identify the primary clinical syndrome from the patient's presentation.
The patient has systemic sclerosis and presents with new-onset malignant hypertension, acute kidney injury, and microangiopathic hemolytic anemia (schistocytes).
These findings form the classic triad of Scleroderma Renal Crisis (SRC).
2
Determine the optimal initial treatment for this specific condition.
ACE inhibitors (such as captopril) are the primary intervention.
SRC is driven by extreme activation of the renin-angiotensin-aldosterone system due to renal vascular damage. ACE inhibitors directly counteract this mechanism.

Key Concept

Scleroderma Renal Crisis (SRC) presents with malignant hypertension and oliguric acute renal failure in a patient with systemic sclerosis; the primary treatment is immediate initiation of an ACE inhibitor.
Estimated Time:45s
Question 2302Question →

A 68-year-old man comes to the emergency department complaining of progressive shortness of breath and an increasingly productive cough over the last 3 days. He notes his sputum has changed from clear to thick and yellowish-green. His medical history is significant for chronic obstructive pulmonary disease (COPD) and a 45-pack-year smoking history. Temperature is 37.6°C (99.7°F), blood pressure is 138/86 mmHg, pulse is 92/min, and respiratory rate is 22/min. Oxygen saturation is 89% on room air. Physical examination reveals a barrel-shaped chest with diffuse bilateral expiratory wheezing and a prolonged expiratory phase. Jugular venous pressure is normal, and there is no lower extremity edema. A bedside chest radiograph demonstrates hyperinflated lungs with flattened diaphragms, but no focal consolidations, pleural effusions, or cardiomegaly. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Administer inhaled bronchodilators, systemic corticosteroids, and an oral macrolide antibiotic

Answer

The most appropriate next step is to administer inhaled bronchodilators, systemic corticosteroids, and an oral macrolide antibiotic.
The correct answer includes the three mainstays of therapy for an acute exacerbation of chronic obstructive pulmonary disease (COPD) with infectious signs: inhaled bronchodilators (e.g., albuterol and ipratropium), systemic corticosteroids (e.g., oral prednisone), and a targeted antibiotic (e.g., azithromycin or doxycycline). This patient presents with the classic cardinal symptoms of a COPD exacerbation (increased dyspnea, increased sputum volume, and increased sputum purulence). The presence of purulent sputum specifically dictates the need for antibiotic therapy to cover common respiratory pathogens (such as Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis).

Step-by-Step Solution

1
Analyze the patient's clinical presentation and vital signs.
The patient has increased dyspnea, increased sputum volume, and increased sputum purulence (changing to yellowish-green) in the setting of chronic COPD.
Identifying the three cardinal symptoms of an acute exacerbation of COPD determines the need for comprehensive medical therapy.
2
Rule out alternative causes of acute dyspnea using physical exam and imaging.
Heart failure is highly unlikely due to the normal jugular venous pressure, absence of peripheral edema, and a chest radiograph showing only hyperinflation without cardiomegaly or effusions.
Differentiating between a primary pulmonary etiology and a cardiovascular one ensures targeted therapy and avoids harmful interventions like unnecessary diuresis.
3
Determine the appropriate therapeutic interventions based on established guidelines.
Select short-acting bronchodilators, systemic corticosteroids, and targeted, narrow-spectrum antibiotics.
Standard of care for a moderate to severe COPD exacerbation with purulent sputum requires all three modalities to reduce airway inflammation, relieve bronchospasm, and treat the underlying bacterial trigger.

Key Concept

Management of Acute Exacerbation of COPD
Question 2303Question →

A 5454-year-old man undergoing induction chemotherapy for acute myeloid leukemia presents to the emergency department with a new-onset fever of 38.9∘C38.9^\circ\text{C} (102.0∘F102.0^\circ\text{F}) and chills. He has an indwelling central venous catheter. His blood pressure is 105/65 mm Hg105/65 \text{ mm Hg}, heart rate is 112/min112/\text{min}, and respiratory rate is 18/min18/\text{min}. Physical examination reveals no obvious source of infection, and the catheter site appears clean without erythema or fluctuance. Laboratory studies demonstrate an absolute neutrophil count of 200/μL200/\mu\text{L}. Arrange the following management steps in the most appropriate chronological sequence for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: 1) Obtain blood cultures, 2) Administer empiric antibiotics within 60 minutes, 3) Obtain a chest radiograph and complete the diagnostic workup, 4) Reassess clinical response and cultures at 48-72 hours, and 5) Discontinue antibiotics upon neutrophil recovery.
The precise chronological management of febrile neutropenia is designed to minimize mortality. Blood cultures must be drawn first to avoid sterilization. Because delays in therapy significantly increase mortality, empiric antipseudomonal antibiotics must be administered next, strictly within 6060 minutes of triage. Consequently, diagnostic imaging such as a chest radiograph must follow, rather than precede, antibiotic administration. Patients are reassessed at 4848-7272 hours when preliminary cultures result, and antibiotics are ultimately discontinued only when the patient has been afebrile for 4848 hours and the absolute neutrophil count is ≥500/μL\geq 500/\mu\text{L}.

Step-by-Step Solution

1
Recognize the clinical emergency
Identify that the patient has high-risk febrile neutropenia (ANC <500/μL< 500/\mu\text{L}).
Febrile neutropenia carries a high risk of rapid clinical deterioration and death if not treated emergently.
2
Prioritize microbiological sampling
Draw at least two sets of blood cultures (central and peripheral).
Cultures must be obtained before antibiotics to ensure the highest probability of identifying the causative pathogen.
3
Initiate life-saving therapy
Administer broad-spectrum antipseudomonal antibiotics.
Antibiotics must be given within 6060 minutes of presentation. Delays to perform imaging or other procedures are strictly contraindicated.
4
Complete the diagnostic workup
Perform a chest radiograph and other directed tests.
Imaging helps identify a localized source of infection but must logically and safely follow the administration of empiric therapy.
5
Reassess and plan for de-escalation
Review cultures at 4848-7272 hours and eventually stop antibiotics only when ANC is ≥500/μL\geq 500/\mu\text{L} and the patient is afebrile.
This strategy ensures appropriate duration of coverage while preventing premature cessation that could lead to fatal relapse.

Key Concept

Febrile neutropenia is an infectious disease emergency requiring blood cultures followed immediately by empiric antipseudomonal antibiotics (within 6060 minutes), prior to any imaging studies. Therapy is continued until neutrophil recovery (ANC ≥500/μL\geq 500/\mu\text{L}).
Question 2304Question →

As part of an introductory hematopathology module, a medical trainee is asked to correlate microscopic cellular abnormalities with their corresponding disease states. Match each classic peripheral blood smear description with the diagnosis it most strongly suggests.

Click a left item, then click its matching right item

Items

Hypersegmented neutrophils
Auer rods
Smudge cells
Schistocytes

Matches

Show answer & explanation

Answer

Hypersegmented neutrophils match with Megaloblastic anemia; Auer rods match with Acute myeloid leukemia; Smudge cells match with Chronic lymphocytic leukemia; Schistocytes match with Microangiopathic hemolytic anemia.
Each classic morphological finding directly corresponds to the underlying pathophysiology of a specific hematologic disorder: impaired DNA synthesis yields hypersegmented neutrophils, abnormal myeloblast granulation produces Auer rods, clonal fragile B-cells manifest as smudge cells, and intravascular mechanical shearing creates schistocytes.

Step-by-Step Solution

1
Identify the cellular origin and pathophysiology of hypersegmented neutrophils.
Linked to impaired DNA synthesis affecting myeloid maturation, specifically pointing to Megaloblastic anemia.
Vitamin B12 and folate are required for normal DNA synthesis; deficiency leads to nuclear-cytoplasmic asynchrony.
2
Recognize the clinical significance of Auer rods.
Matched with Acute myeloid leukemia.
Auer rods confirm the myeloblastic lineage of the leukemic cells, ruling out lymphoblastic leukemias.
3
Recall the conditions associated with fragile white blood cells that rupture on smear preparation (smudge cells).
Matched with Chronic lymphocytic leukemia.
CLL is characterized by a monoclonal proliferation of incompetent, structurally fragile B lymphocytes.
4
Determine the mechanism behind red blood cell fragmentation (schistocytes).
Matched with Microangiopathic hemolytic anemia.
Intravascular shearing by microthrombi (as in TTP, HUS, or DIC) produces these distinct fragmented shapes.

Key Concept

Recognition of pathognomonic peripheral blood smear findings is a foundational diagnostic skill in hematology that directly guides subsequent clinical workup.
Estimated Time:45s
Question 2305Question →

A 3535-year-old man presents to the emergency department with a 33-day history of increasing fatigue, spontaneous gum bleeding, and a diffuse petechial rash. He has no significant past medical history and takes no medications. Vital signs are temperature 37.2∘C37.2^\circ\text{C} (99.0∘F99.0^\circ\text{F}), heart rate 105/min105/\text{min}, blood pressure 110/70 mmHg110/70\text{ mmHg}, and respiratory rate 18/min18/\text{min}. Physical examination reveals pale conjunctivae, continuous oozing from the gingival margins, diffuse petechiae on the lower extremities, and large ecchymoses on the trunk. There is no hepatosplenomegaly or lymphadenopathy.

Laboratory results are as follows:

Laboratory TestResultReference Range
Hemoglobin8.2 g/dL8.2\text{ g/dL}13.5−17.5 g/dL13.5-17.5\text{ g/dL}
Platelets18,000/mm318,000/\text{mm}^3150,000−400,000/mm3150,000-400,000/\text{mm}^3
Leukocytes2,500/mm32,500/\text{mm}^34,500−11,000/mm34,500-11,000/\text{mm}^3
Prothrombin time (PT)22 sec22\text{ sec}11−15 sec11-15\text{ sec}
Partial thromboplastin time (PTT)55 sec55\text{ sec}25−40 sec25-40\text{ sec}
Fibrinogen85 mg/dL85\text{ mg/dL}200−400 mg/dL200-400\text{ mg/dL}
D-dimer5,400 ng/mL5,400\text{ ng/mL}<500 ng/mL< 500\text{ ng/mL}

A peripheral blood smear reveals numerous large, atypical mononuclear cells with abundant cytoplasm containing multiple primary granules and prominent needle-like cytoplasmic inclusions.

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Administration of all-trans retinoic acid

Answer

Administration of all-trans retinoic acid
This patient's presentation of pancytopenia, spontaneous mucosal bleeding, and a peripheral smear demonstrating numerous large mononuclear cells with prominent needle-like cytoplasmic inclusions (Auer rods) is highly suspicious for Acute Promyelocytic Leukemia (APL). APL, the M3 subtype of acute myeloid leukemia, is notorious for presenting with a life-threatening bleeding diathesis due to severe Disseminated Intravascular Coagulation (DIC). The leukemic promyelocytes contain primary granules rich in tissue factor and other procoagulants; when these cells turn over or are destroyed, the release of these factors triggers massive activation of the coagulation cascade. This is confirmed by the patient's markedly prolonged PT and PTT, hypofibrinogenemia, and elevated D-dimer. APL is a true oncologic emergency characterized by a high early mortality rate, primarily from intracranial or pulmonary hemorrhage. The most critical step in management is the immediate administration of all-trans retinoic acid (ATRA). ATRA overcomes the differentiation block caused by the characteristic PML−RARAPML-RARA fusion gene (a result of the t(15;17)t(15;17) translocation), allowing the malignant promyelocytes to mature into functional neutrophils. This differentiation rapidly halts the release of procoagulants and resolves the DIC. Crucially, ATRA must be initiated empirically the moment APL is suspected based on clinical features and peripheral smear findings; treatment must never be delayed to wait for confirmatory bone marrow biopsy or cytogenetic results.

Step-by-Step Solution

1
Analyze the patient's clinical presentation.
The patient exhibits severe, spontaneous mucosal and cutaneous bleeding (oozing gums, petechiae, ecchymoses) in an acute setting.
Bleeding diathesis narrows the differential to platelet disorders, coagulation factor deficiencies, or a consumptive process.
2
Interpret the laboratory and peripheral smear data.
Labs show pancytopenia, marked prolongation of PT and PTT, severe hypofibrinogenemia, and markedly elevated D-dimer. The smear shows atypical cells with needle-like inclusions (Auer rods).
The abnormal coagulation panel with low fibrinogen and high D-dimer confirms Disseminated Intravascular Coagulation (DIC). The smear findings are pathognomonic for Acute Promyelocytic Leukemia (APL).
3
Determine the pathogenesis of the current emergency.
The abnormal promyelocytes in APL are filled with primary granules that contain procoagulants (like tissue factor). The release of these contents heavily activates the coagulation cascade, driving the catastrophic DIC.
Understanding the driver of the DIC dictates that treating the underlying leukemia is the most effective way to stop the coagulopathy.
4
Select the most appropriate immediate intervention.
All-trans retinoic acid (ATRA) must be administered immediately.
ATRA forces the malignant promyelocytes to differentiate into mature neutrophils, abruptly halting the release of procoagulants. It should be given immediately upon clinical suspicion, prior to genetic confirmation of the t(15;17)t(15;17) translocation.

Key Concept

Acute Promyelocytic Leukemia (APL) is a medical emergency that frequently presents with severe Disseminated Intravascular Coagulation (DIC). Upon clinical or morphologic suspicion (e.g., Auer rods on smear), all-trans retinoic acid (ATRA) must be initiated immediately to prevent fatal hemorrhage.
Estimated Time:1m 30s
Question 2306Question →

A 4-year-old boy is brought to the pediatric clinic in late September for a well-child visit. He was diagnosed with moderate-to-severe Crohn disease 6 months ago. His current medications include infliximab, a tumor necrosis factor-alpha (TNF-α) inhibitor, which has led to clinical remission and appropriate weight gain. He has no other medical conditions. His immunizations were up to date until his 18-month visit. He is now due for his routine preschool vaccinations, and the parents also request the seasonal influenza vaccine. His vital signs are temperature 36.8°C (98.2°F), heart rate 98/min, and respiratory rate 20/min. Physical examination is unremarkable.

Which of the following is the most appropriate immunization plan for this patient today?

Show answer & explanation

Answer: Administer DTaP, IPV, and inactivated influenza vaccines; defer MMR and varicella vaccines

Answer

The most appropriate plan is to administer the inactivated vaccines (DTaP, IPV, and inactivated influenza) and to defer the live-attenuated vaccines (MMR and varicella).
The correct plan involves administering only the inactivated vaccines (DTaP, IPV, and inactivated influenza) and deferring the live-attenuated vaccines (MMR and varicella). This patient is receiving infliximab, a TNF-α inhibitor, which is a potent immunosuppressant. In severely immunocompromised patients, live-attenuated vaccines are strictly contraindicated because the vaccine strain viruses can undergo uncontrolled replication, leading to severe and potentially fatal disseminated disease. Conversely, inactivated vaccines cannot cause infectious disease and are safe to administer to immunocompromised individuals. They should be given on schedule to provide necessary protection, even though the overall immune response might be slightly blunted.

Step-by-Step Solution

1
Evaluate the patient's immune status based on his current medications.
The patient is taking infliximab, a biologic TNF-α inhibitor, which causes significant systemic immunosuppression.
Determining the immune status is the critical first step before administering any vaccines, as it dictates vaccine safety.
2
Determine the safety profile of the indicated preschool vaccines (DTaP, IPV, MMR, varicella, and seasonal influenza) in an immunocompromised host.
DTaP, IPV, and standard seasonal influenza vaccines are inactivated and safe. MMR and varicella are live-attenuated vaccines and are contraindicated.
Live-attenuated vaccines can cause uncontrolled viral replication and severe disease in immunocompromised patients, whereas inactivated vaccines pose no infectious risk.
3
Formulate the appropriate immunization plan for today's visit.
The plan must include the administration of the safe inactivated vaccines (DTaP, IPV, influenza) and the deferral of the contraindicated live vaccines (MMR, varicella).
This strategy maximizes the patient's protection against vaccine-preventable diseases without exposing him to the dangers of live vaccine administration.

Key Concept

In severely immunocompromised pediatric patients, such as those on TNF-α inhibitors, live-attenuated vaccines (e.g., MMR, varicella) are strictly contraindicated due to the risk of disseminated infection, whereas inactivated vaccines (e.g., DTaP, IPV) are safe and should be administered according to the routine schedule.
Estimated Time:1m 30s
Question 2307Question →

A 53-year-old woman is brought to the emergency department by her husband due to a severe headache, blurred vision, and progressive confusion over the past 24 hours. Her past medical history is significant for diffuse cutaneous systemic sclerosis diagnosed three years ago. Two weeks ago, she was started on oral prednisone for worsening joint pain and skin tightness. Her temperature is 37.1°C (98.8°F), blood pressure is 225/115 mmHg, and pulse is 102/min. Physical examination shows thickened, tight skin over her face, forearms, and chest. Neurological examination reveals a confused patient but is negative for focal motor or sensory deficits. Fundoscopy demonstrates bilateral flame-shaped hemorrhages and papilledema. Laboratory studies show:

TestResult
Hemoglobin9.1 g/dL
Platelets85,000/mm³
Leukocytes8,400/mm³
Creatinine3.2 mg/dL

A peripheral blood smear demonstrates 3-5 schistocytes per high-power field. Her baseline creatinine one month ago was 0.8 mg/dL. Which of the following is the most appropriate next step in the pharmacologic management of this patient's condition?

Show answer & explanation

Answer: Oral captopril

Answer

Oral captopril
The correct answer is oral captopril. This patient is presenting with Scleroderma Renal Crisis (SRC), a severe and potentially fatal complication that occurs in about 10-15% of patients with diffuse cutaneous systemic sclerosis. SRC is characterized by the sudden onset of marked hypertension (often malignant, presenting with end-organ damage such as encephalopathy and papilledema) and rapidly progressive oliguric acute kidney injury. Approximately half of patients also develop microangiopathic hemolytic anemia (MAHA) and thrombocytopenia, as seen in this patient with schistocytes on her blood smear. A major known trigger for SRC is the recent use of moderate-to-high dose corticosteroids (e.g., prednisone), which this patient recently started taking. The pathogenesis of SRC involves acute intimal proliferation and narrowing of the renal arteries, leading to decreased renal perfusion, massive renin release, and severe activation of the renin-angiotensin-aldosterone system (RAAS). Therefore, the specific and life-saving treatment is rapid RAAS blockade with a short-acting ACE inhibitor, such as oral captopril. Captopril should be initiated immediately and titrated to carefully lower the blood pressure. Notably, ACE inhibitors are the treatment of choice for SRC even in the setting of acute kidney injury, a situation where they are typically contraindicated in other disease states.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and medical history.
The patient has diffuse cutaneous systemic sclerosis and presents with new-onset malignant hypertension, encephalopathy, acute kidney injury, and microangiopathic hemolytic anemia.
Identifying the classic triad of malignant hypertension, rapidly progressive acute renal failure, and systemic sclerosis establishes the primary clinical syndrome.
2
Synthesize the laboratory findings with the clinical picture.
The presence of schistocytes, thrombocytopenia, and elevated creatinine confirms Scleroderma Renal Crisis (SRC), which was likely precipitated by her recent initiation of corticosteroid therapy.
Differentiating SRC from primary thrombotic microangiopathies (like thrombotic thrombocytopenic purpura) is critical for selecting the correct physiological target for treatment.
3
Determine the most appropriate pharmacologic intervention based on pathophysiology.
Immediate administration of a short-acting ACE inhibitor (captopril) is required.
SRC is driven by massive, unabated renin-angiotensin-aldosterone system (RAAS) activation; ACE inhibitors specifically reverse this intense vasospasm and are the only agents proven to restore renal perfusion and improve outcomes.

Key Concept

Scleroderma renal crisis (SRC) is a life-threatening complication of systemic sclerosis characterized by malignant hypertension, acute kidney injury, and often microangiopathic hemolytic anemia. It is treated primarily with ACE inhibitors (e.g., captopril) despite the presence of renal failure.
Estimated Time:1m 30s
Question 2308Question →

A physician is evaluating a hospitalized patient with chronic kidney disease who has developed anuria and profound muscle weakness over the past twelve hours. An electrocardiogram demonstrates prolonged PR intervals, widened QRS complexes, and tall, peaked T waves. A point-of-care basic metabolic panel reveals a serum potassium level of 7.47.4 mEq/L. Arrange the following therapeutic interventions in the most appropriate chronological order of administration for this patient's acute management.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Intravenous calcium gluconate, 2) Intravenous regular insulin and dextrose, 3) Oral sodium zirconium cyclosilicate.
The fundamental treatment algorithm for severe hyperkalemia with electrocardiographic changes prioritizes immediate survival over actual potassium removal. Intravenous calcium gluconate works within 1 to 3 minutes to stabilize the resting membrane potential of cardiac myocytes, making it the mandatory first step. Next, intravenous regular insulin with dextrose acts within 15 to 30 minutes to push potassium inside the cells, providing a rapid but temporary drop in serum potassium. Finally, because the total body potassium remains elevated, a definitive removal method such as oral sodium zirconium cyclosilicate (a gastrointestinal potassium binder) is given, though its slow onset of action (hours) makes it inappropriate for acute cardiac stabilization.

Step-by-Step Solution

1
Identify the primary immediate threat to the patient's life.
The patient has severe hyperkalemia (7.47.4 mEq/L) with significant electrocardiogram changes, placing the patient at imminent risk of ventricular fibrillation or asystole.
Recognizing the acute cardiac risk dictates that the very first intervention must directly protect the heart.
2
Select the agent for cardiac membrane stabilization.
Intravenous calcium gluconate is identified as the first-line therapy.
Calcium directly antagonizes the membrane actions of potassium without actually lowering the serum potassium level, acting within minutes to stabilize the myocardium.
3
Select the agent for rapid intracellular shifting of potassium.
Intravenous regular insulin (with dextrose to prevent hypoglycemia) is chosen next.
Once the heart is protected, potassium must be rapidly cleared from the serum. Insulin drives potassium into cells, temporarily lowering serum levels within 15 to 30 minutes.
4
Select the agent for definitive total-body potassium elimination.
Oral sodium zirconium cyclosilicate (a gastrointestinal cation exchanger) is scheduled last.
Shifting agents only hide potassium inside cells. A binder or dialytic therapy is required to permanently excrete the potassium, but this process takes hours to work.

Key Concept

The algorithmic management of acute, severe hyperkalemia with electrocardiographic changes always follows a strict three-step chronological sequence: cardiac membrane stabilization (calcium), intracellular shifting (insulin/dextrose, albuterol), and definitive total-body elimination (gastrointestinal binders, diuretics, or dialysis).
Estimated Time:45s
Question 2309Question →

An occupational health physician evaluates a 4949-year-old man who reports a progressive decline in energy levels, persistent chills, and lower extremity swelling over the past six months. The patient mentions he struggles to stay awake during daytime meetings and feels short of breath when climbing the stairs to his office. He takes no daily medications. His temperature is 36.1∘C36.1^{\circ}\text{C} (97.0∘F97.0^{\circ}\text{F}), blood pressure is 105/65 mm Hg105/65\text{ mm Hg}, pulse is 52/min52/\text{min}, and respiratory rate is 12/min12/\text{min}. Physical examination demonstrates non-pitting edema of the bilateral lower extremities, coarse hair, and delayed relaxation of deep tendon reflexes. Lung fields are clear to auscultation. Laboratory results show a serum free T4 level of 0.3 ng/dL0.3\text{ ng/dL} (Normal: 0.9−1.7 ng/dL0.9-1.7\text{ ng/dL}) and a thyroid-stimulating hormone (TSH) level of 1.8 mIU/L1.8\text{ mIU/L} (Normal: 0.5−5.0 mIU/L0.5-5.0\text{ mIU/L}). Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Measurement of early morning serum cortisol

Answer

Measurement of early morning serum cortisol is the appropriate next step to rule out concurrent central adrenal insufficiency before initiating levothyroxine therapy.
The correct answer addresses the critical sequence of evaluating pituitary hormone deficiencies. This patient presents with classic symptoms of severe hypothyroidism, including bradycardia, non-pitting edema (myxedema), delayed deep tendon reflexes, and fatigue. However, the laboratory results reveal a low free T4 level with an inappropriately normal TSH. This pattern confirms central (secondary) hypothyroidism, localizing the defect to the anterior pituitary gland or hypothalamus. Because pituitary pathology often impairs multiple hormone axes simultaneously, patients with central hypothyroidism frequently have coexisting central adrenal insufficiency. Initiating levothyroxine therapy accelerates the basal metabolic rate and the hepatic clearance of cortisol. If levothyroxine is given to a patient with unrecognized and untreated adrenal insufficiency, it can rapidly deplete their minimal cortisol reserves and precipitate a life-threatening adrenal crisis. Therefore, it is mandatory to assess the adrenal axis with an early morning serum cortisol level (and potentially an ACTH stimulation test) before initiating thyroid hormone replacement. If adrenal insufficiency is confirmed, glucocorticoids must be started before or simultaneously with levothyroxine.

Step-by-Step Solution

1
Interpret the thyroid function laboratory results.
The patient has a low free T4 but an inappropriately normal TSH.
This specific pattern indicates central (secondary) hypothyroidism, pointing to a pituitary or hypothalamic disorder, rather than primary thyroid failure (which would present with an elevated TSH).
2
Identify potential coexisting endocrine abnormalities associated with the diagnosis.
A pituitary disorder that causes central hypothyroidism often concurrently causes central adrenal insufficiency (secondary hypocortisolism).
The anterior pituitary secretes multiple hormones, and mass lesions or structural defects typically affect multiple endocrine axes simultaneously.
3
Determine the safest management sequence for initiating hormone replacement.
Evaluate the adrenal axis with an early morning cortisol level before administering levothyroxine.
Levothyroxine increases the basal metabolic rate and hepatic clearance of cortisol. If a patient has undiagnosed adrenal insufficiency, starting levothyroxine can acutely deplete remaining cortisol stores and trigger a fatal adrenal crisis.

Key Concept

Patients with central hypothyroidism must be evaluated for concomitant central adrenal insufficiency before starting levothyroxine therapy to prevent the precipitation of an adrenal crisis.
Question 2310Question →

A 68-year-old woman is evaluated in the preoperative clinic prior to an elective right total knee arthroplasty. Her past medical history is notable for osteoarthritis and well-controlled hypertension. The patient reports feeling well and specifically denies any dysuria, urinary frequency, suprapubic pain, or fever. Her vital signs are within normal limits. As part of her preoperative workup, a urinalysis is obtained which demonstrates 15 white blood cells per high-power field and is positive for leukocyte esterase and nitrites. A subsequent urine culture grows >10510^5 colony-forming units/mL of *Escherichia coli*. Susceptibility testing shows the organism is sensitive to nitrofurantoin, trimethoprim-sulfamethoxazole, ciprofloxacin, and ceftriaxone. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Proceed with the scheduled surgery without specific treatment for the bacteriuria

Answer

Proceed with the scheduled surgery without specific treatment for the bacteriuria
The correct approach is to proceed with the scheduled surgery without specific treatment for the bacteriuria. This patient has asymptomatic bacteriuria (ASB), which is defined as the isolation of a specified quantitative count of bacteria in an appropriately collected urine specimen from a person without signs or symptoms of a urinary tract infection. According to current guidelines, screening for and treating ASB is NOT indicated for patients undergoing non-urologic surgeries, including orthopedic procedures like total knee arthroplasty. Treatment in this scenario does not reduce the risk of surgical site infections or symptomatic urinary tract infections. Instead, unnecessary antibiotic use contributes to antimicrobial resistance, increases the risk of *Clostridioides difficile* infection, and exposes the patient to potential drug toxicities. The only widely accepted indications for screening and treating ASB are pregnancy and prior to urologic procedures where mucosal bleeding is anticipated.

Step-by-Step Solution

1
Evaluate the patient's symptoms and laboratory findings to establish a clinical diagnosis.
The patient has positive urine culture and urinalysis findings but absolutely no urinary or systemic symptoms.
Differentiating asymptomatic bacteriuria from a true urinary tract infection is based entirely on the presence or absence of clinical symptoms.
2
Determine the indications for treating asymptomatic bacteriuria.
The patient is not pregnant and is undergoing an orthopedic procedure (total knee arthroplasty), not a urologic procedure.
Asymptomatic bacteriuria is only treated in specific populations (pregnant women) or prior to urologic procedures with anticipated mucosal bleeding.
3
Select the appropriate management strategy based on the diagnosis and patient context.
No antibiotic therapy is indicated for the bacteriuria; the surgery can proceed as planned.
Treating asymptomatic bacteriuria in this setting does not improve outcomes and contributes to antibiotic resistance.

Key Concept

Asymptomatic bacteriuria should not be screened for or treated in the general population, including prior to non-urologic surgeries such as orthopedic joint replacements.
Question 2311Question →

A 68-year-old man with a history of ischemic cardiomyopathy (left ventricular ejection fraction 35%), severe chronic obstructive pulmonary disease (COPD), and type 2 diabetes mellitus is evaluated in the intensive care unit. He was admitted 3 days ago for urosepsis after presenting with fever, hypotension, and altered mental status. On admission, he received 4 liters of intravenous normal saline and was started on empiric intravenous vancomycin and cefepime.

Blood cultures from admission grew *Escherichia coli* at 24 hours. Today, sensitivities resulted showing the organism is susceptible to ceftriaxone, ciprofloxacin, and trimethoprim-sulfamethoxazole, but resistant to ampicillin.

The patient is now afebrile and his blood pressure has stabilized off vasopressors. However, the nurse reports that he has developed worsening dyspnea over the last 12 hours.

Vital signs are:
Blood pressure: 128/78 mmHg128/78 \text{ mmHg}
Heart rate: 102/min102/\text{min}
Respiratory rate: 26/min26/\text{min}
SpO2SpO_2: 89%89\% on room air

Physical examination reveals an elevated jugular venous pressure of 11 cm H2O11 \text{ cm } H_2O. Lung auscultation demonstrates bibasilar crackles and scattered expiratory wheezes. There is 2+ bilateral pitting lower extremity edema.

Laboratory results:
ParameterValue
Serum sodium136 mEq/L136 \text{ mEq/L}
Serum potassium4.2 mEq/L4.2 \text{ mEq/L}
Serum chloride104 mEq/L104 \text{ mEq/L}
Serum bicarbonate12 mEq/L12 \text{ mEq/L}
Blood urea nitrogen42 mg/dL42 \text{ mg/dL}
Serum creatinine1.9 mg/dL1.9 \text{ mg/dL}
Thyroid-stimulating hormone (TSH)0.2 μU/mL0.2 \ \mu\text{U/mL} (Normal: 0.4−4.0 μU/mL0.4-4.0 \ \mu\text{U/mL})
Free T40.7 ng/dL0.7 \text{ ng/dL} (Normal: 0.8−1.8 ng/dL0.8-1.8 \text{ ng/dL})

Arterial blood gas (room air):
pH: 7.277.27
pCO2pCO_2: 26 mmHg26 \text{ mmHg}
pO2pO_2: 64 mmHg64 \text{ mmHg}

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Administer intravenous furosemide and change antibiotics to intravenous ceftriaxone

Answer

The most appropriate management is to administer intravenous furosemide to treat the acute decompensated heart failure and de-escalate the antibiotic regimen to intravenous ceftriaxone for targeted treatment of the E. coli bacteremia.
The correct sequence of actions requires synthesizing multiple systemic issues. First, the patient's severe dyspnea, wheezing, and bibasilar crackles following 4 liters of normal saline indicate acute decompensated heart failure (ADHF). Because the patient has underlying COPD, it is critical to rule out a COPD exacerbation. The ABG shows a metabolic acidosis (HCO3−HCO_3^- of 12) with a calculated high anion gap (136−104−12=20136 - 104 - 12 = 20), typical in resolving sepsis or uremia. Using Winter's formula to determine expected respiratory compensation: pCO2=(1.5×12)+8=26±2pCO_2 = (1.5 \times 12) + 8 = 26 \pm 2. Since the measured pCO2pCO_2 is exactly 26 mmHg, there is no superimposed respiratory acidosis. If the patient were having a severe COPD exacerbation causing his current distress, he would have relative CO2 retention. Therefore, the treatment is diuresis (furosemide). Second, the patient has *E. coli* bacteremia susceptible to ceftriaxone. Continuing empiric vancomycin and cefepime violates antibiotic stewardship; therapy must be de-escalated. Finally, the abnormal thyroid labs reflect euthyroid sick syndrome, which requires no treatment.

Step-by-Step Solution

1
Assess the cause of respiratory distress using the physical exam and arterial blood gas.
The patient has elevated jugular venous pressure, crackles, edema, and a high anion gap metabolic acidosis. Applying Winter's formula (1.5×12+8=26±21.5 \times 12 + 8 = 26 \pm 2), the expected pCO2pCO_2 perfectly matches the measured pCO2pCO_2 (26 mmHg26 \text{ mmHg}).
This rules out a superimposed respiratory acidosis (which would be expected in a severe COPD exacerbation causing dyspnea) and confirms the dyspnea and wheezing ('cardiac asthma') are due to acute decompensated heart failure from aggressive fluid resuscitation.
2
Evaluate the current antibiotic regimen against the culture sensitivity data.
The patient is on empiric vancomycin and cefepime, but blood cultures grew *Escherichia coli* susceptible to ceftriaxone.
According to antimicrobial stewardship principles, therapy must be de-escalated to the most targeted, narrow-spectrum effective agent once sensitivities are known.
3
Interpret the thyroid function tests in the context of critical illness.
The patient has low TSH and low free T4.
In the ICU setting, this pattern is classic for euthyroid sick syndrome (nonthyroidal illness syndrome). Administration of exogenous thyroid hormone is not indicated and can be deleterious.

Key Concept

Management of acute decompensated heart failure (ADHF) in critically ill patients, utilizing Winter's formula to differentiate ADHF from COPD exacerbation, paired with mandatory antibiotic de-escalation.
Estimated Time:3m 0s
Question 2312Question →

A 55-year-old man is admitted to the hospital after a lymph node biopsy confirmed the diagnosis of a highly aggressive non-Hodgkin lymphoma. He is scheduled to receive his first cycle of multi-agent chemotherapy in 2424 hours. He currently has no acute complaints. Vital signs are within normal limits. Laboratory studies reveal the following:

Laboratory TestResultReference Range
Hemoglobin11.2 g/dL11.2 \text{ g/dL}13.5−17.5 g/dL13.5-17.5 \text{ g/dL}
Leukocyte count45,000/mm345,000/\text{mm}^34,500−11,000/mm34,500-11,000/\text{mm}^3
Platelet count140,000/mm3140,000/\text{mm}^3150,000−400,000/mm3150,000-400,000/\text{mm}^3
Serum creatinine0.9 mg/dL0.9 \text{ mg/dL}0.6−1.2 mg/dL0.6-1.2 \text{ mg/dL}
Uric acid9.8 mg/dL9.8 \text{ mg/dL}4.0−8.5 mg/dL4.0-8.5 \text{ mg/dL}
Lactate dehydrogenase (LDH)1,500 U/L1,500 \text{ U/L}140−280 U/L140-280 \text{ U/L}

Which of the following is the most appropriate next step in management to prevent acute renal complications in this patient?

Show answer & explanation

Answer: Initiate aggressive intravenous hydration and administer allopurinol

Answer

Initiate aggressive intravenous hydration and administer allopurinol
The correct answer is to initiate aggressive intravenous hydration and administer allopurinol. This patient has a highly aggressive lymphoma with a high tumor burden, as evidenced by significantly elevated baseline lactate dehydrogenase (LDH) and uric acid levels. He is at very high risk for tumor lysis syndrome (TLS) once multi-agent chemotherapy is initiated. TLS results from the massive destruction of tumor cells, leading to the rapid release of intracellular contents, including potassium, phosphate, and nucleic acids (which are metabolized into uric acid). The precipitation of uric acid and calcium-phosphate crystals in the renal tubules can cause severe acute kidney injury. Therefore, the standard of care for high-risk patients is prophylaxis with aggressive intravenous hydration to maintain robust urine output and the administration of a xanthine oxidase inhibitor (allopurinol) or a recombinant urate oxidase (rasburicase) to lower serum uric acid levels before chemotherapy begins.

Step-by-Step Solution

1
Evaluate the patient's clinical presentation and baseline laboratory values.
The patient has a highly aggressive lymphoma with markedly elevated baseline uric acid and LDH.
These findings indicate a high tumor burden and rapid cellular turnover.
2
Identify the primary risk associated with initiating multi-agent chemotherapy in this specific setting.
The patient is at exceptionally high risk for developing tumor lysis syndrome (TLS).
Chemotherapy will cause massive lysis of tumor cells, releasing intracellular contents (potassium, phosphate, and nucleic acids) into the systemic circulation, which can precipitate acute kidney injury.
3
Determine the most appropriate prophylactic intervention to prevent TLS-induced renal failure.
Aggressive intravenous hydration and a uric acid-lowering agent (such as allopurinol or rasburicase) must be started.
Intravenous fluids maintain high urine output to flush out metabolites, while allopurinol inhibits xanthine oxidase, preventing the formation of uric acid from released nucleic acids.

Key Concept

Patients with bulky, rapidly proliferating tumors (e.g., high-grade non-Hodgkin lymphoma, acute leukemia) are at high risk for tumor lysis syndrome when starting chemotherapy. Prophylaxis with aggressive intravenous hydration and allopurinol (or rasburicase) is essential to prevent acute uric acid nephropathy and subsequent renal failure.
Estimated Time:1m 0s
Question 2313Question →

A 3232-year-old man comes to the clinic for routine sexually transmitted infection screening. He is currently asymptomatic and has no history of genital ulcers, diffuse rashes, or neurologic symptoms. He reports having unprotected intercourse with a new male sexual partner 22 months ago. He has no known prior history of syphilis or other sexually transmitted infections. Vital signs are within normal limits. Physical examination reveals no oral, genital, or perianal lesions, and no lymphadenopathy is appreciated. The clinic laboratory utilizes the reverse sequence algorithm for syphilis screening. The initial *Treponema pallidum* enzyme immunoassay (EIA) returns reactive. A reflex rapid plasma reagin (RPR) test is nonreactive. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Perform a Treponema pallidum particle agglutination (TP-PA) test

Answer

The most appropriate next step is to perform a second, different treponemal test, specifically the Treponema pallidum particle agglutination (TP-PA) test.
The correct answer is to perform a Treponema pallidum particle agglutination (TP-PA) test. The reverse sequence algorithm for syphilis screening starts with a highly sensitive treponemal test (like an EIA or CIA). If reactive, it reflexes to a non-treponemal test (like RPR) to gauge disease activity. When results are discordant (reactive EIA, nonreactive RPR), it is unclear if the patient has early syphilis (RPR not yet positive), a history of treated syphilis (treponemal tests remain positive for life), or a false-positive EIA. Because this patient has no history of treated syphilis, a false-positive EIA must be differentiated from early infection. The CDC mandates running a second, different treponemal test (such as TP-PA) to resolve this discordance. If the TP-PA is reactive, the patient has syphilis and requires treatment; if nonreactive, the initial EIA was a false positive.

Step-by-Step Solution

1
Identify the screening algorithm being used.
The clinic uses the reverse sequence algorithm (treponemal test first, followed by a non-treponemal test).
Understanding the algorithm is necessary to interpret the sequence of laboratory results.
2
Interpret the specific laboratory results provided in the vignette.
The initial EIA (treponemal) is reactive, but the reflex RPR (non-treponemal) is nonreactive. This is a discordant result.
Discordant results in the reverse algorithm require further investigation because they can represent early primary syphilis, previously treated syphilis, or a false-positive EIA.
3
Determine the guideline-directed next step for discordant reverse sequence results.
The CDC recommends performing a second, different treponemal test (like TP-PA) to confirm if the initial EIA was a true positive or a false positive.
If the TP-PA is nonreactive, the EIA was a false positive, and no treatment is needed. If the TP-PA is reactive, the patient has syphilis (either early or latent) and requires treatment since he has no history of prior therapy.

Key Concept

In the reverse sequence algorithm for syphilis screening, a reactive treponemal test (EIA/CIA) followed by a nonreactive non-treponemal test (RPR/VDRL) must be followed by a second, different treponemal test (TP-PA) to rule out a false-positive initial result.
Estimated Time:1m 30s
Question 2314Question →

A 42-year-old woman is evaluated in the hospital on the fourth day of admission for acute severe pancreatitis. She has been receiving intravenous fluids via a right internal jugular central venous catheter placed on admission. Yesterday, her temperature briefly spiked to 38.3°C (100.9°F). One set of peripheral blood cultures and one set from the central venous catheter were obtained at that time. Today, she reports that her abdominal pain is improving. Her temperature is 37.1°C (98.8°F), blood pressure is 118/76 mm Hg, pulse is 82/min, and respirations are 14/min. Physical examination shows a clean central catheter insertion site with no surrounding erythema or induration. Laboratory studies show a leukocyte count of 9,200/mm³. The aerobic bottle of the peripheral blood culture set is growing coagulase-negative staphylococci after 24 hours of incubation. The anaerobic peripheral bottle and both bottles from the central catheter show no growth. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Observation without antimicrobial therapy

Answer

Observation without antimicrobial therapy
Observation without antimicrobial therapy is the correct management because the culture result most likely represents contamination. Coagulase-negative staphylococci (CoNS) are common commensals of the human skin. While they can cause true device-associated infections (such as central line-associated bloodstream infections), true bacteremia typically presents with positive growth in multiple culture bottles drawn from different sites. In this patient, only one of the four bottles grew CoNS, and the patient is clinically stable with a clean catheter site. Therefore, this finding represents a contaminated blood draw, and no antibiotics or line removal is indicated.

Step-by-Step Solution

1
Assess the patient's clinical stability and potential sources of infection.
The patient is hemodynamically stable, afebrile, and clinically improving from her pancreatitis. The central catheter site appears uninfected.
Determines the urgency of intervention and identifies localized signs of true infection.
2
Interpret the blood culture results in the context of the clinical picture.
Only one out of four total bottles (one peripheral aerobic) is positive for coagulase-negative staphylococci (CoNS).
CoNS are ubiquitous skin flora. Determining if they represent true bacteremia requires multiple positive bottles drawn from separate venipunctures.
3
Determine the appropriate management step.
Observation without antimicrobial therapy is indicated.
A single positive bottle for CoNS in the absence of prosthetic hardware or severe clinical deterioration strongly points to sample contamination during phlebotomy, requiring no treatment.

Key Concept

Interpretation of blood culture contamination versus true bacteremia, emphasizing antibiotic stewardship by avoiding treatment for single-bottle positive coagulase-negative staphylococci.
Question 2315Question →

An oncologist is called to evaluate a 5858-year-old man in the hospital who has a history of metastatic non-small cell lung cancer. The patient reports a 11-week history of worsening, band-like thoracic back pain that is particularly severe when lying supine. Over the last 2424 hours, he has noticed progressive heaviness in both legs and has not voided urine since the previous evening. On neurologic examination, there is 3/53/5 muscle strength in the lower extremities bilaterally, pronounced hyperreflexia at the patellae, and a sensory deficit to pinprick extending distally from the umbilicus. Arrange the following steps in the most appropriate chronological order for the management of this patient's current condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing suspected malignant epidural spinal cord compression is to first administer intravenous dexamethasone, followed by an emergent whole-spine MRI, evaluating the imaging for spinal stability, and finally proceeding with definitive surgery or radiation.
The correct chronological sequence prioritizes immediate neurologic preservation over diagnostic confirmation. In a patient with known malignancy who presents with classic signs of epidural spinal cord compression (ESCC)—such as severe back pain, lower extremity weakness, and autonomic dysfunction (urinary retention)—the immediate priority is the administration of high-dose intravenous glucocorticoids (e.g., dexamethasone). This step is critical to reduce vasogenic edema and prevent irreversible paraplegia, and it must not be delayed for imaging. Once corticosteroids are given, an emergent MRI of the entire spine is obtained to confirm the diagnosis and detect multiple lesions. The imaging is then evaluated to assess spinal mechanical stability (e.g., via the SINS score). Finally, definitive therapy is initiated, choosing between surgical decompression (often preferred for unstable spines or radioresistant tumors) and external beam radiation therapy.

Step-by-Step Solution

1
Administer high-dose intravenous dexamethasone.
Decreases peritumoral vasogenic edema.
Immediate corticosteroid therapy reduces pressure on the spinal cord and preserves neurologic function, taking absolute priority over diagnostic imaging.
2
Obtain an emergent MRI of the entire spine.
Visualizes the spinal cord, vertebrae, and epidural space.
MRI is required to confirm the diagnosis, locate the exact level of compression, and identify any synchronous asymptomatic lesions elsewhere in the spine.
3
Evaluate imaging for degree of compression and spinal stability.
Determines the mechanical integrity of the spine.
The choice of definitive therapy depends heavily on whether the spine is mechanically stable and the radiosensitivity of the underlying tumor.
4
Proceed with targeted surgical decompression or radiation therapy.
Provides definitive local control of the metastatic lesion.
Surgical resection or radiation relieves the compression long-term and prevents future irreversible neurologic deterioration.

Key Concept

The initial management of suspected neoplastic epidural spinal cord compression (ESCC) requires immediate administration of systemic glucocorticoids before obtaining confirmatory imaging.
Question 2316Question →

Match the following clinical scenarios of oncologic therapy and associated toxicities with the most appropriate pharmacological rescue or prophylactic agent.

Click a left item, then click its matching right item

Items

A 42-year-old woman with breast cancer receives a chemotherapy agent known to cause dose-dependent generation of free radicals, leading to cumulative, irreversible dilated cardiomyopathy.
A 35-year-old man with non-Hodgkin lymphoma receives an alkylating agent that is metabolized in the kidney to acrolein, placing him at high risk for severe hemorrhagic cystitis.
A 22-year-old man with acute lymphoblastic leukemia receives a high-dose antimetabolite that competitively inhibits dihydrofolate reductase, leading to severe myelosuppression.
A 15-year-old boy with Burkitt lymphoma is initiating induction chemotherapy for a massive tumor burden, placing him at high risk for acute kidney injury from profound hyperuricemia.

Matches

Show answer & explanation

Answer

The correct matches align each specific chemotherapy-induced toxicity mechanism with its targeted pharmacological rescue or prophylactic agent: Anthracycline cardiotoxicity requires Dexrazoxane; Acrolein-induced cystitis requires Mesna; Methotrexate myelosuppression requires Leucovorin; and hyperuricemia in Tumor Lysis Syndrome is treated with Rasburicase.
Each pair correctly matches a specific oncologic toxicity or complication with its mechanistically appropriate pharmacological intervention. Dexrazoxane chelates iron to prevent anthracycline cardiotoxicity. Mesna binds acrolein to prevent cyclophosphamide-induced cystitis. Leucovorin bypasses DHFR inhibition to rescue normal cells from methotrexate. Rasburicase degrades uric acid to prevent nephropathy in tumor lysis syndrome.

Step-by-Step Solution

1
Analyze the first scenario to identify the underlying chemotherapy agent and its toxic mechanism.
The agent described is an anthracycline (e.g., doxorubicin), which causes free-radical mediated dilated cardiomyopathy.
Recognizing the pathophysiology is required to select the correct cardioprotectant, which is Dexrazoxane.
2
Identify the cause and prevention of hemorrhagic cystitis in the second scenario.
The alkylating agent (cyclophosphamide) produces acrolein, which is neutralized by Mesna.
Mesna specifically concentrates in the bladder to bind acrolein, preventing urothelial toxicity.
3
Determine the rescue agent for the patient receiving the dihydrofolate reductase inhibitor in the third scenario.
The drug is methotrexate, and its toxicity is mitigated by Leucovorin (folinic acid).
Leucovorin provides the active form of folate, bypassing the blocked enzyme and rescuing rapidly dividing normal cells.
4
Select the most appropriate prophylactic agent for severe hyperuricemia in the fourth scenario.
The high tumor burden puts the patient at risk for tumor lysis syndrome, which is aggressively managed with Rasburicase.
Rasburicase enzymatically degrades uric acid to allantoin, rapidly preventing urate crystal nephropathy in high-risk patients.

Key Concept

Pharmacological prevention and rescue of specific chemotherapy-induced toxicities and oncologic emergencies.
Estimated Time:2m 0s
Question 2317Question →

A 2222-year-old woman is brought to the emergency department by her college roommate due to bizarre behavior over the past 44 days. The roommate states that the patient has locked herself in her room, claims that hidden cameras are recording her thoughts, and frequently talks to people who are not present. She has no personal or family history of psychiatric illness. Over the past month, the patient has complained of severe fatigue, diffuse joint pain, and increased hair shedding. Her temperature is 37.9∘C37.9^{\circ}C (100.2∘F100.2^{\circ}F), blood pressure is 146/92146/92 mm Hg, and pulse is 9898/min. Physical examination reveals an erythematous, scaling rash across her cheeks and the bridge of her nose that spares the nasolabial folds. Painless ulcers are noted on the hard palate. The proximal interphalangeal and metacarpophalangeal joints are mildly swollen, warm, and tender to palpation bilaterally.

Laboratory studies show:
TestResult
Hemoglobin9.69.6 g/dL
Leukocytes3,100/mm33,100/mm^3
Platelets98,000/mm398,000/mm^3
Serum creatinine1.61.6 mg/dL
Thyroid-stimulating hormone (TSH)2.42.4 mU/L (normal: 0.5−5.00.5-5.0 mU/L)
Free T41.21.2 ng/dL (normal: 0.9−2.40.9-2.4 ng/dL)
Urinalysis3+3+ protein, 10−1510-15 erythrocytes/hpf, negative leukocyte esterase

Which of the following is the most appropriate initial treatment targeting the underlying etiology of this patient's condition?

Show answer & explanation

Answer: Intravenous methylprednisolone

Answer

Intravenous methylprednisolone
The correct answer is high-dose intravenous corticosteroids. This patient presents with acute psychosis in the setting of severe, undiagnosed Systemic Lupus Erythematosus (SLE). Her clinical picture features multiple classic SLE criteria: malar rash, painless oral ulcers, inflammatory arthritis, alopecia, pancytopenia, and lupus nephritis (proteinuria, hematuria, and elevated creatinine). The acute onset of hallucinations and paranoia represents neuropsychiatric SLE (lupus cerebritis), a severe, organ-threatening manifestation of the disease. The primary treatment for life-threatening or organ-threatening SLE flares is immediate immunosuppression with high-dose intravenous corticosteroids (e.g., methylprednisolone), often followed by cyclophosphamide or mycophenolate mofetil.

Step-by-Step Solution

1
Analyze the patient's systemic symptoms and physical examination findings.
The patient has a malar rash, oral ulcers, nondeforming polyarthritis, and alopecia.
These are classic clinical criteria for Systemic Lupus Erythematosus (SLE).
2
Evaluate the laboratory results.
Pancytopenia (anemia, leukopenia, thrombocytopenia) and acute kidney injury with proteinuria and hematuria are present.
These findings confirm hematologic and renal (lupus nephritis) involvement of SLE, demonstrating a severe systemic flare.
3
Interpret the acute psychiatric presentation in the context of the systemic disease.
The acute onset of hallucinations and paranoia over 4 days in a patient with an active SLE flare points to neuropsychiatric SLE (lupus cerebritis/psychosis).
Medical causes of psychosis must be ruled out before diagnosing primary psychiatric conditions.
4
Determine the appropriate disease-modifying treatment for organ-threatening SLE.
High-dose intravenous corticosteroids are required.
Severe SLE manifestations (CNS involvement and active nephritis) require aggressive immunosuppression to halt end-organ damage.

Key Concept

Neuropsychiatric Systemic Lupus Erythematosus (SLE) requires urgent recognition of underlying autoimmune etiology and immediate treatment with high-dose intravenous corticosteroids.
Question 2318Question →

A 2-day-old male newborn is evaluated in the nursery for a new-onset skin rash. He was born at 39 weeks gestation via uncomplicated spontaneous vaginal delivery. Apgar scores were 8 and 9 at 1 and 5 minutes, respectively. The infant has been breastfeeding well and has had normal bowel and bladder function. Temperature is 37.1 C (98.8 F), heart rate is 140/min, and respiratory rate is 40/min. Physical examination reveals multiple erythematous macules and papules with central 1- to 2-mm yellow-white pustules scattered across the trunk and proximal extremities. The palms and soles are spared. The remainder of the examination is unremarkable. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Reassurance and observation

Answer

Reassurance and observation
The correct answer is reassurance and observation. The patient presents with classic features of erythema toxicum neonatorum (ETN), a benign, idiopathic eruption seen in up to 50% of full-term neonates. ETN typically appears in the first 24 to 72 hours of life and is characterized by erythematous macules, papules, and pustules distributed predominantly over the trunk and proximal extremities, sparing the palms and soles. The infant is otherwise entirely asymptomatic and well-appearing. The condition is self-limited, usually resolving without scarring within one week, so no diagnostic workup or pharmacologic treatment is necessary.

Step-by-Step Solution

1
Evaluate the clinical status of the patient.
The neonate is full-term, afebrile, feeding well, and has reassuring vital signs.
Establishing that the infant is well-appearing helps rule out serious systemic infections (e.g., neonatal sepsis, disseminated herpes simplex virus).
2
Analyze the morphology and distribution of the rash.
The rash consists of erythematous macules and papules with central yellow-white pustules on the trunk and proximal extremities, sparing palms and soles.
This specific morphological pattern and distribution on day 2 of life is highly characteristic of erythema toxicum neonatorum.
3
Determine the appropriate management.
No diagnostic testing or pharmacologic intervention is recommended; the family should be reassured.
Erythema toxicum neonatorum is a benign, self-limited, idiopathic condition that spontaneously resolves within a week.

Key Concept

Erythema toxicum neonatorum is a common, benign, self-limiting neonatal rash presenting as erythematous macules with central pustules on the trunk and extremities, managed solely with reassurance.
Question 2319Question →

A 2-month-old girl is brought to the clinic for her first well-child examination. She was born at 39 weeks gestation via spontaneous vaginal delivery. Her mother has a history of severe, refractory Crohn's disease, which has been managed with regular infusions of infliximab throughout the pregnancy, with the final dose administered at 36 weeks gestation. The infant's newborn screen was normal. She has been exclusively breastfed and is gaining weight well. On examination, the infant appears well. She smiles responsively, makes cooing sounds, and tracks the examiner's face past the midline. When placed in the prone position, she is able to lift her head to 45 degrees. The mother expresses concern that the infant is not yet reaching for objects or rolling over. Her tone and reflexes are normal. She previously received the Hepatitis B vaccine at birth. Which of the following is the most appropriate next step in management regarding her immunizations and development?

Show answer & explanation

Answer: Reassure the mother regarding development; administer DTaP, Hib, PCV, IPV, and Hepatitis B vaccines; and withhold the rotavirus vaccine

Answer

The most appropriate management is to reassure the mother regarding the infant's normal development, administer all routine inactivated vaccines (DTaP, Hib, PCV, IPV, Hepatitis B), and withhold the live rotavirus vaccine.
The correct management is to reassure the mother regarding the infant's normal development, administer the routine inactivated vaccines, and withhold the live rotavirus vaccine. At 2 months of age, normal milestones include social smiling, cooing, tracking past the midline, and lifting the head to 45 degrees when prone. The mother's concerns regarding the lack of reaching for objects and rolling over are unfounded, as these are typically 4-month milestones; therefore, reassurance is appropriate rather than a developmental referral. Regarding immunizations, the routine 2-month schedule includes DTaP, Hib, PCV, IPV, Hepatitis B, and rotavirus. However, this infant was exposed to infliximab (a TNF-alpha inhibitor) in utero during the third trimester. Monoclonal IgG antibodies actively cross the placenta and can cause profound immunosuppression in the infant for up to 6 months after birth. Consequently, the administration of live-attenuated vaccines, such as the oral rotavirus vaccine, is strictly contraindicated during this period due to the risk of severe, disseminated vaccine-strain infection. In contrast, all inactivated vaccines are safe and should be administered according to the normal schedule.

Step-by-Step Solution

1
Assess the infant's developmental milestones.
The infant smiles, coos, tracks past the midline, and lifts her head 45 degrees when prone. The lack of reaching and rolling over is entirely normal at 2 months of age.
To address the mother's concerns and determine if a developmental referral is clinically warranted.
2
Determine the routine immunization requirements at 2 months of age.
The standard schedule includes DTaP, Hib, PCV, IPV, Hepatitis B, and rotavirus vaccines.
To establish the baseline recommended vaccines before considering maternal and patient history for contraindications.
3
Identify any contraindications based on the infant's in utero exposure.
The infant was exposed to infliximab (an IgG1 monoclonal antibody) in utero. These biologic agents actively cross the placenta and cause systemic immunosuppression in the infant that can persist for up to 6 months.
Maternal use of biologic immunosuppressants dictates the safety profile of live vaccines in the neonate.
4
Synthesize the findings to formulate the safest management plan.
Reassure the mother about development. Administer all inactivated vaccines, as they are safe. Withhold the live rotavirus vaccine to prevent disseminated vaccine-strain infection.
To provide necessary preventive care while avoiding life-threatening complications in an immunocompromised host.

Key Concept

Infants exposed to biological immunomodulators (e.g., infliximab, adalimumab) in utero during the second or third trimester should not receive live-attenuated vaccines (like rotavirus) for the first 6 months of life, though all inactivated vaccines should be administered on the standard schedule.
Question 2320Question →

A 54-year-old woman is evaluated in the emergency department for a 24-hour history of severe headache, fever, and progressive confusion. Her temperature is 39.4°C (102.9°F), blood pressure is 110/68 mm Hg, and pulse is 114/min. On physical examination, the patient is lethargic and oriented to person only. Neck stiffness is elicited upon flexion. There are no focal neurologic deficits. Arrange the following management steps in the most appropriate chronological sequence for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to obtain blood cultures, followed immediately by administering empiric antibiotics and dexamethasone, then performing a computed tomography of the head, and finally performing a lumbar puncture.
In patients with suspected bacterial meningitis who have altered mental status, new-onset seizures, focal neurologic deficits, or papilledema, a computed tomography scan of the head is required before a lumbar puncture to rule out increased intracranial pressure. However, obtaining the imaging can delay definitive diagnosis. Therefore, blood cultures should be drawn immediately, followed by the administration of empiric antibiotics and dexamethasone. Once therapy is initiated, the computed tomography scan can be performed safely, followed by the lumbar puncture. This sequence prevents dangerous delays in treatment while mitigating the risk of brain herniation.

Step-by-Step Solution

1
Identify the suspected diagnosis and the need for urgent intervention.
The patient has signs of acute bacterial meningitis along with altered mental status (lethargy, confusion).
Recognizing the triad of meningitis alongside altered mental status dictates the specific diagnostic and therapeutic algorithm to avoid complications.
2
Determine if there are indications for cranial imaging before a lumbar puncture.
The patient's altered mental status is a direct indication for head imaging prior to a lumbar puncture.
Performing a lumbar puncture in the presence of increased intracranial pressure or a mass lesion can precipitate fatal brain herniation.
3
Sequence the required interventions prioritizing rapid antimicrobial delivery.
Blood cultures must be drawn first, followed by antibiotics, then the CT scan, and finally the lumbar puncture.
Antibiotics must never be delayed by the wait for a CT scan. Blood cultures must be drawn before antibiotics to avoid sterilizing the sample.

Key Concept

Algorithmic management of suspected bacterial meningitis in patients with indications for imaging prior to lumbar puncture.
Estimated Time:1m 30s
PreviousPage 116 / 414Next
All practice questions — USMLE Step 2 CK | Examkin